Accelera Innovations, Inc (ACNV)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Aug 18, 2025
Accelera Innovations Revenue
Accelera Innovations had revenue of $1.25K in the twelve months ending September 30, 2017, down -108.07% year-over-year. In the year 2016, Accelera Innovations had annual revenue of $2.75K, down -99.76%.
Revenue (ttm)
1.25K
Revenue Growth
-108.07%
P/S Ratio
6.51
Revenue / Employee
416.67
Employees
3
Market Cap
8.14K
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2016 | 2.75K | -1.13M | -99.76% |
Dec 31, 2015 | 1.13M | -1.58M | -58.25% |
Dec 31, 2014 | 2.72M | 2.34M | 622.43% |
Dec 31, 2013 | 375.89K | - | - |
Dec 31, 2012 | - | - | - |
Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Elite Pharmaceuticals | 105.45M |
Tian'an Technology Group | 2.12M |
Glass House Brands | 221.55M |
Northwest Biotherapeutics | 1.09M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.17M |
Longduoduo Company | 4.99M |